The United Kingdom has long been a nerve centre for biomedical innovation. From the clustered labs of the ‘golden triangle’ to specialist cell‑biology units in Scotland and the thriving biotech corridors of the North West, the demand for research peptides has never been more dynamic. Peptides – chains of amino acids that can mimic natural…